Curve Therapeutics

BIO international Convention 2026 22-25 June 2026 San Diego Cora Griffin, Head of BD will be attending The post BIO international Convention 2026 appeared first on Curve Therapeutics.

BioEquity Europe 2026 4-6 May 2026 Prague Cora Griffin, Head of BD will be giving a company presentation The post BioEquity Europe 2026 appeared first on Curve Therapeutics.

22nd Anglonordic Life Sciences Conference 23 April 2026 London Cora Griffin, Head of BD will be giving a company presentation The post 22nd Anglonordic Life Sciences Conference appeared first on Curve Therapeutics.

The post There are currently no vacancies appeared first on Curve Therapeutics.

LSX World Congress Europe 2026 25-26 March 2026 Lisbon, Portugal Cora Griffin, Head of BD will be joining the panel Platform Technologies: Building a Company vs. a Single Asset The post LSX World Congress Europe 2026 appeared first on Curve Therapeutics.

JP Morgan 44th Annual Healthcare Conference 12-15 January 2026 San Francisco, US CEO Simon Kerry and Head of Business Development Cora Griffin attending The post JP Morgan 44th Annual Healthcare Conference appeared first on Curve Therapeutics.

Job Title: Laboratory Operations/Health and Safety Manager Office Location: Southampton Science Park, Delta House, Enterprise Road, Southampton SO16 7NS Curve Therapeutics is a highly innovative Biotech company that is delivering pioneering and groundbrea

Curve Therapeutics CEO Simon Kerry spoke with Amy Brown of Biotech TV on the background, science, and development plans for the Company. Curve CSO Ali Tavassoli also spoke with Amy for a deep dive on the science behind Curve's mammalian cell-based Microcy

Following the award of the Royal Society of Chemistry's Interdisciplinary Prize, Curve Co-Founder and CSO Ali Tavassoli spoke with Eva Haas of Optimum Strategic Communications for an episode of the Optimum Perspectives podcast. Ali reflects on his scienti

Awarded in recognition of excellence in research and innovation and contribution to scientific progress Reflects the revolutionary potential of Curve's gene-encoded Microcycle platform to unlock the therapeutic potential of intracellular targets Southampt